Bumetanide
Active substance: bumetanide
INJECTION · BUMETANIDE .25 mg/mL
United StatesActive
Marketing holder: Qilu Pharmaceutical Co., Ltd.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- BUMETANIDE · .25 mg/mL
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2979-744d-a072-f30a3163b051,01a1208c-2b87-756f-adff-9c3c629ce3aa,01a1208c-2b91-724a-89bd-b0d7043ee604,01a1208c-2b91-7f32-89bd-b0d705afa0a9,01a1208c-3736-749d-9f56-934c519dfcf6;count=126 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 67184-0593
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAMUSCULAR, INTRAVENOUS
Sources
- product · openFDA NDC · 67184-0593 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 67184-0593 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 67184-0593 · Verified 2026-10-09 · open in source